IGF2 and liver cancer: HBx upregulates IGF‐1R expression and increases IGF‐2 transcription by interacting with the Sp1 binding site on IGF‐2 promoter, which collectively lead to IGF‐2 overexpression and aberrant IGF signaling, accelerating liver cancer progression [483].